Electronic prescribing of controlled substances (EPCS) moved from recommended practice to federal requirement for a large segment of U.S. prescribers. Section 2003 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) Act, enacted in 2018, requires that Schedule II–V controlled substances prescribed under Medicare Part D be transmitted electronically. After multiple enforcement delays, the Centers for Medicare & Medicaid Services (CMS) entered the active-enforcement phase for the requirement.
The threshold
The rule is not absolute on the first prescription. CMS framed compliance around a percentage threshold — prescribers are expected to transmit the large majority of their applicable Part D controlled-substance prescriptions electronically, with defined exceptions for circumstances where e-prescribing is not feasible. The early enforcement posture emphasized notification of non-compliant prescribers rather than immediate penalties, with additional provisions phased in for long-term care settings.
Why it was built this way
EPCS exists to address two problems at once: the operational friction of paper controlled-substance prescriptions and the fraud and diversion risks they carry. Electronic transmission, paired with the DEA’s two-factor identity-proofing requirements, creates an auditable trail from prescriber to pharmacy that paper cannot match.
The standards underneath
EPCS rides on the same NCPDP SCRIPT messaging that carries ordinary electronic prescriptions, layered with the DEA’s identity and security controls. That shared foundation is why a practice already e-prescribing routine medications usually finds the controlled-substance step is a configuration and credentialing exercise rather than a new system.
What it means for Arizona
Arizona prescribers were already operating in an environment shaped by state-level e-prescribing expectations, so the federal mandate reinforced a direction many had taken. The practical advice from a neutral standpoint: confirm your EHR or e-prescribing platform is certified for EPCS, verify your identity-proofing is current, and understand the exception categories before assuming a workflow is non-compliant. Our Pharmacy & Supply work area covers e-prescribing fundamentals in plain language, and the glossary defines the acronyms that surround this rule.